S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
Log in

ETR:AFX - Carl Zeiss Meditec Stock Price, Forecast & News

€103.10
-7.00 (-6.36 %)
(As of 12/6/2019 04:00 PM ET)
Today's Range
€103.00
Now: €103.10
€103.90
50-Day Range
€92.55
MA: €103.13
€111.00
52-Week Range
€60.90
Now: €103.10
€111.50
Volume561,633 shs
Average Volume94,405 shs
Market Capitalization$9.22 billion
P/E Ratio60.22
Dividend Yield0.50%
BetaN/A
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery. Read More…

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-3641-2200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.38 billion
Cash Flow€0.21 per share
Book Value€14.66 per share

Profitability

Miscellaneous

Employees3,179
Market Cap$9.22 billion
Next Earnings Date12/6/2019 (Estimated)
OptionableNot Optionable

Receive AFX News and Ratings via Email

Sign-up to receive the latest news and ratings for AFX and its competitors with MarketBeat's FREE daily newsletter.


Carl Zeiss Meditec (ETR:AFX) Frequently Asked Questions

What is Carl Zeiss Meditec's stock symbol?

Carl Zeiss Meditec trades on the ETR under the ticker symbol "AFX."

When is Carl Zeiss Meditec's next earnings date?

Carl Zeiss Meditec is scheduled to release their next quarterly earnings announcement on Friday, December 6th 2019. View Earnings Estimates for Carl Zeiss Meditec.

What price target have analysts set for AFX?

8 brokerages have issued 12 month target prices for Carl Zeiss Meditec's stock. Their forecasts range from €80.00 to €110.00. On average, they expect Carl Zeiss Meditec's stock price to reach €93.86 in the next year. This suggests that the stock has a possible downside of 9.0%. View Analyst Price Targets for Carl Zeiss Meditec.

What is the consensus analysts' recommendation for Carl Zeiss Meditec?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Carl Zeiss Meditec in the last year. There are currently 2 sell ratings, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Carl Zeiss Meditec.

Has Carl Zeiss Meditec been receiving favorable news coverage?

Media headlines about AFX stock have trended extremely negative this week, according to InfoTrie. The research firm rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Carl Zeiss Meditec earned a coverage optimism score of -4.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Carl Zeiss Meditec.

Who are some of Carl Zeiss Meditec's key competitors?

What other stocks do shareholders of Carl Zeiss Meditec own?

Who are Carl Zeiss Meditec's key executives?

Carl Zeiss Meditec's management team includes the folowing people:
  • Dr. Ludwin Monz, Pres, CEO & Chairman of Management Board (Age 56)
  • Mr. Justus Felix Wehmer, CFO & Member of the Management Board (Age 54)
  • Mr. Jan Willem de Cler, Head of Surgical Ophthalmology & Member of Management Board
  • Mr. Sebastian Frericks, Director of Investor Relations
  • Mr. Martin Wiechmann, Head of the Planetarium Bus. Unit

What is Carl Zeiss Meditec's stock price today?

One share of AFX stock can currently be purchased for approximately €103.10.

How big of a company is Carl Zeiss Meditec?

Carl Zeiss Meditec has a market capitalization of $9.22 billion and generates $1.38 billion in revenue each year. Carl Zeiss Meditec employs 3,179 workers across the globe.View Additional Information About Carl Zeiss Meditec.

What is Carl Zeiss Meditec's official website?

The official website for Carl Zeiss Meditec is http://www.zeiss.com/.

How can I contact Carl Zeiss Meditec?

Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The company can be reached via phone at +49-3641-2200.


MarketBeat Community Rating for Carl Zeiss Meditec (ETR AFX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  187 (Vote Outperform)
Underperform Votes:  216 (Vote Underperform)
Total Votes:  403
MarketBeat's community ratings are surveys of what our community members think about Carl Zeiss Meditec and other stocks. Vote "Outperform" if you believe AFX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AFX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Featured Article: Quiet Period Expirations

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel